Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,879 papers from all fields of science
Search
Sign In
Create Free Account
janssen
Known as:
janssens
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Pharmaceutical Services
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study
M. Cavo
,
R. Hájek
,
+22 authors
P. Sonneveld
2017
Corpus ID: 220332375
BackgroundThe EMN02/HO95 trial is the largest multicenter, randomized, phase 3 study conducted in the novel agent era and aimed…
Expand
2017
2017
Gamma irradiation-induced absorption in single-domain and periodically-poled KTiOPO4 and Rb:KTiOPO4
R. Coetzee
,
S. Duzellier
,
J. Dherbecourt
,
A. Zukauskas
,
M. Raybaut
,
V. Pasiskevicius
2017
Corpus ID: 13143171
We investigate the effect of gamma radiation on flux grown KTiOPO4 and Rb:KTiOPO4 samples, as well as their periodically poled…
Expand
2017
2017
R-DHA-Oxaliplatin before Autologous Stem Cell Transplantation Prolongs PFS and OS As Compared to R-DHA-Carboplatin and R-DHA-Cisplatin in Patients with Mantle Cell Lymphoma, a Subgroup Analysis of…
S. Gouill
,
C. Thieblemont
,
+23 authors
O. Hermine
2017
Corpus ID: 201158918
BACKGROUND. The LyMA (ClinicalTrials.gov, NCT00921414) trial is a prospective international randomized phase III trial that…
Expand
2017
2017
First Report on Overall Survival (OS) and Improved Progression Free Survival (PFS) in a Completed Phase 2a Study of Melflufen in Advanced Relapsed Refractory Multiple Myeloma (RRMM)
P. Richardson
,
S. Bringhen
,
+12 authors
P. Sonneveld
2017
Corpus ID: 202810835
Background: Melflufen is a next generation alkylator, designed for efficient targeting of tumor cells with a unique mechanism of…
Expand
Review
2016
Review
2016
Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)
U. Vitolo
,
M. Trněný
,
+18 authors
L. Sehn
2016
Corpus ID: 208436118
Background: Rituximab (R) plus CHOP (R-CHOP) is standard-of-care treatment for previously untreated diffuse large B-cell lymphoma…
Expand
2016
2016
Techno-Economic Assessment of Retrofitting Concepts for Parabolic Trough Power Plants with Solar Towers
Mathias Weidle
2016
Corpus ID: 56250412
This thesis investigates the cost-efficiency of retrofitting concepts based on the addition of a solar tower to an existing…
Expand
2014
2014
Covenant of Mayors:Fuel Switch and Sustainable Demand in signatories from "stress test" countriesBulgaria, Estonia, Latvia, Lithuania, Slovakia, Finland
Kona Albana
,
Melica Giulia
,
+5 authors
Bertoldi Paolo
2014
Corpus ID: 131516632
The Covenant of Mayors (CoM) is the mainstream European movement involving local authorities voluntarily committing to meet and…
Expand
2012
2012
1p22 and 1p32 Deletions Are Independent Prognosis Factors in Young Patients with Myeloma: The IFM Experience On 1195 Patients
B. Hébraud
,
X. Leleu
,
+25 authors
H. Avet-Loiseau
2012
Corpus ID: 208385451
Abstract 933 Cytogenetics findings are the most important pronostic factor in multiple myeloma (MM) with age and ISS. IMW…
Expand
2010
2010
The sustainability of cultural diversity : nations, cities and organizations
M. Janssens
,
Myriam
,
Bechtoldt
,
A. Ruijter
,
Dino Pinelli
2010
Corpus ID: 127398009
Foreword Introduction PART I: CONCEPTUAL INTRODUCTION 1. Sustainable Diversity Selma van Londen and Arie de Ruijter 2. A…
Expand
2008
2008
Employing the Benefits of Atomic and Molecular Spectroscopy in a Combined X-ray Fluorescence/Raman Microanalyser
K. Janssens
2008
Corpus ID: 53692445
X-ray fluorescence analysis (XRF) is a widely applied routine method for inorganic analysis of a variety of materials; compact ED…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required